Modular Design of a Novel Chimeric Protein with Combined Thrombin Inhibitory Activity and Plasminogen-Activating Potential

Author： Wirsching F.   Luge C.   Schwienhorst A.  

Publisher： Academic Press

ISSN： 1096-7192

Source： Molecular Genetics and Metabolism, Vol.75, Iss.3, 2002-03, pp. : 250-259

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GH-Inhibitory Activity of Novel Somatostatin Agonists: Potential Applications in Acromegaly

By  

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 5, Iss. 3, 2005-06 ,pp. : 277-291

Bentham Science Publishers

Access to resources Recommend Favorite

A novel tumor necrosis factor- inhibitory protein, TIP-B1

By Berleth E.S.   Henn A.D.   Gurtoo H.L.   Wollman R.   Alderfer J.L.   Mihich E.   Ehrke M.J.  

International Journal of Immunopharmacology, Vol. 22, Iss. 12, 2000-12 ,pp. : 1137-1142

Elsevier

Access to resources Recommend Favorite

Activating and inhibitory FcγRs in autoimmune disorders

By Nimmerjahn Falk  

Springer Seminars in Immunopathology, Vol. 28, Iss. 4, 2006-12 ,pp. : 305-319

Springer Publishing Company

Access to resources Recommend Favorite

Novel mutation in the PML/RAR chimeric gene exhibits dramatically decreased ligand-binding activity and confers acquired resistance to retinoic acid in acute promyelocytic leukemia

By Takayama N.   Kizaki M.   Hida T.   Kinjo K.   Ikeda Y.  

Experimental Hematology, Vol. 29, Iss. 7, 2001-07 ,pp. : 864-872

Elsevier

Access to resources Recommend Favorite

Multiple potential regulatory sites of TLR4 activation induced by LPS as revealed by novel inhibitory human TLR4 mAbs

By Tsukamoto Hiroki   Fukudome Kenji   Takao Shoko   Tsuneyoshi Naoko   Ihara Hideyuki   Ikeda Yoshitaka   Kimoto Masao  

International Immunology, Vol. 24, Iss. 8, 2012-08 ,pp. : 495-506

Oxford University Press

Access to resources Recommend Favorite